evidence: Renal function parameters were similar between study arms although a small increase in NGAL was detected among TDF-treated patients.
intervention: Abacavir/lamivudine (ABC/3TC) or tenofovir/emtricitabine (TDF/FTC)
comparator: Zidovudine/lamivudine (AZT/3TC)
outcome: Renal function parameters